13.07.2015 Views

registration in malaysia - Kementerian Kesihatan Malaysia

registration in malaysia - Kementerian Kesihatan Malaysia

registration in malaysia - Kementerian Kesihatan Malaysia

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BPFK Introduction Def<strong>in</strong>ition Health SupplementRegistration Criteria Food/Drug Interface ConclusionContents


Where are welocated?National Pharmaceutical Control BureauM<strong>in</strong>istry of Health <strong>Malaysia</strong>Jalan Universiti, P.O.Box 319,46730 Petal<strong>in</strong>g Jaya, Selangor<strong>Malaysia</strong>Tel : 603-7957 3611Fax: 603-7956 2924/ 7958 1312


CONTROL OF DRUG AND COSMETICSACT 1984 (REVISED 2006)Sub Regulation 7(1)No person shall-manufacture-sell-supply-import-possess-or adm<strong>in</strong>ister any product


CONTROL OF DRUG AND COSMETICSACT 1984 (REVISED 2006)unless:the product is a registered product,andthe person holds the appropriate licenserequired & issued under the CDCR


MALAYSIARegistration and Licens<strong>in</strong>g Activityunder the Drug Control Authority (DCA))The NPCB acts as the Secretariat to the DCA


PRODUCTREGISTRATION


OBJECTIVE OF REGISTRATION To ensure that allpharmaceutical productwhich is registeredunder DCA is evaluatedon the safety, quality and efficacy


Product RegistrationProduk BaruFasa 1 Fasa 2 Fasa 3 Fasa 4 Fasa 5BioteknologiRegistrationAug 1985(PrescriptionDrugs)Registration1988(OTC)RegistrationJan 1992(TraditionalMedic<strong>in</strong>e)RegistrationFeb 2002(Cosmetics)Notification: 1January 2010RegistrationAugust 2007(Veter<strong>in</strong>ary)Produk Veter<strong>in</strong>ariLicens<strong>in</strong>gMay 1987Licens<strong>in</strong>g1992Licens<strong>in</strong>gManufacturersImportersJan 1999Licens<strong>in</strong>gJan 2004Licens<strong>in</strong>gBahan AktifFarmaseutikalSurveillance1995Surveillance1995Licens<strong>in</strong>gWholesalersJuly 2002Surveillance1999Surveillance2004Surveillance


Registration Fees. Product Classification Process<strong>in</strong>gFees (RM)Analysis fees(RM)Total Fees(RM)1. Health Supplement 1000.00 S<strong>in</strong>gle active<strong>in</strong>gredient:1,200.00Two or moreactive<strong>in</strong>gredients :2,000.002,200.003,000.002. For Export Only HealthSupplement1,000.00 1,000.00


Registration criteria- Applicant must be a locally<strong>in</strong>corporated company,- and be authorized <strong>in</strong> writ<strong>in</strong>g by theproduct owner to be the holder of the<strong>registration</strong> certificate and beresponsible for all matters perta<strong>in</strong><strong>in</strong>gto the <strong>registration</strong> of the product


Product RegistrationREGISTRATION APPLICATIONOn-l<strong>in</strong>e Quest 3 System


Registration procedure- onl<strong>in</strong>ewww.bpfk.gov.my


Registration procedure- onl<strong>in</strong>ewww.bpfk.gov.my


Screen<strong>in</strong>g by Head of HealthSuplemen Unit (KPP)Applicant reply to KPP regard<strong>in</strong>gIncomplete documentationCompleteREGISTRATION PROCESSFLOW CHARTPayment will be asked to be doneFurther evaluation by HealthSupplement OfficerCompleteMeet<strong>in</strong>g ‘Jawatankuasa KerjaPendaftaran’Meet<strong>in</strong>g Drug ControlAuthorityApproveRejectIncompleteReply Through Quest 3to comply to ourrequirementsLetter ofrejection toapplicant*ApplicantIssue <strong>registration</strong> certificate


• PharmaceticalRegistration CriteriaSafety, Quality, Efficacious• Health Supplement/TraditionalSafety and Quality• CosmeticsSafety and Quality


Registration CriteriaProducts ParticularsProduct FormulaProduct NameProduct DescriptionDosage FormDosage-Active<strong>in</strong>gredient-Ban item-Excipient-Compulsorylabell<strong>in</strong>grequirement-AdditionalWarn<strong>in</strong>g/PrecautionLabell<strong>in</strong>g RequirementManufacturerName and address-CPP_GMP-CFSPack<strong>in</strong>g Particulars-Pack size-Type ofconta<strong>in</strong>er


Health Supplement Def<strong>in</strong>itionHealth Supplements shallmeans product that are<strong>in</strong>tended to supplementthe diet taken by mouth <strong>in</strong>forms such as pills,capsules, tablets, liquidsor powders and notrepresented as aconventional food or as asole item of a meal or thediet


Health SupplementRegistration22


Product to be registered underHealth SupplementThe dietary <strong>in</strong>gredients <strong>in</strong> theseproducts may <strong>in</strong>clude:Vitam<strong>in</strong>s, M<strong>in</strong>erals, Am<strong>in</strong>oAcidsNatural substances ofplant/animal orig<strong>in</strong>Enzymes, substances withnutritional /physiologicalfunctionand/orComb<strong>in</strong>ation with selected traditionalsubstance:(eg: Bee Pollen, Blue Algae,Chlorella, Chlorophyll, Alfafa,Spirul<strong>in</strong>a, Garlic)


List B: List of Active <strong>in</strong>gredients that are allowedto be comb<strong>in</strong>ed with active<strong>in</strong>gredients <strong>in</strong> List A1. Acerola2. Aloe vera3. Allium sativum (Garlic)4. Bee pollen5. Bee propolis6. Borago offic<strong>in</strong>alis (Borage oil)7. Chlorella (Chlorella pyrenoidosa,Chlorella sorokianiana, Chlorellavulgaris)8. Chlorophyll9. Camellia s<strong>in</strong>ensis10. Even<strong>in</strong>g primrose oil/Oenotherabiennis11. Ganoderma12. G<strong>in</strong>seng/ Panax g<strong>in</strong>seng16. Medicago sativa (Alfafa)17. P<strong>in</strong>e bark (pycnogenol)/ P<strong>in</strong>us miritus(p<strong>in</strong>us massoniana, p<strong>in</strong>us p<strong>in</strong>aster18. P<strong>in</strong>e pollen19. Propolis20. Rosa can<strong>in</strong>a21. Rose hips22. Rosmar<strong>in</strong>us offic<strong>in</strong>alis23. Royal jelly24. Seaweed25. Shark cartilage26. Shark liver oil27. Spirul<strong>in</strong>a (Spirul<strong>in</strong>a platensis)28. Tagetes erecta (Marigold)29. Vitis v<strong>in</strong>isfera (Grape seed extract)30. Wheat Germ Oil31. Wheat grass13. Hordeum Vulgare (Barley)14. Kelp/ Lam<strong>in</strong>aria sp.15. L<strong>in</strong>um usitatissimum (Flaxseed oil)


HEALTH SUPPLEMENTSREGISTRATION CRITERIASAFETYUpper daily limits set for some vitam<strong>in</strong>s andm<strong>in</strong>erals (Appendix 9 <strong>in</strong> Drug RegistrationGuidance Document)New active <strong>in</strong>gredients / new doseNew comb<strong>in</strong>ationNon permitted/ banned <strong>in</strong>gredientsProduct InformationWarn<strong>in</strong>gs/precautions/drug <strong>in</strong>teractions/adverseeffects


UPPER DAILY LIMITS OF VITAMINS AND MINERALSFOR ADULTS ALLOWED IN DIETARY SUPPLEMENTS1. Vitam<strong>in</strong> A 5000 IU2. Vitam<strong>in</strong> D 400 IU3. Vitam<strong>in</strong> E 400 IU4. Vitam<strong>in</strong> B1 (Thiam<strong>in</strong>e) 300mg5. Vitam<strong>in</strong> B2 (Riboflav<strong>in</strong>e) 30mg6. Vitam<strong>in</strong> B5 (Pantothenic acid) 200mg7. Vitam<strong>in</strong> B6 (Pyridox<strong>in</strong>e) 100mg8. Vitam<strong>in</strong> B12 (Cyanocobalam<strong>in</strong>) 150mcg9. Vitam<strong>in</strong> C (Ascorbic Acid) 1000mg10. Folic acid 15mg 15mg11. Niac<strong>in</strong> (Nicot<strong>in</strong>ic Acid) 500mg12. Niac<strong>in</strong>amide (Nicot<strong>in</strong>amide) 250mg13. Biot<strong>in</strong> 40mg14. Calcium 1400mg15. Copper 2mg16. Iod<strong>in</strong>e 300mcg17. Iron 20mg*18. Magnesium 400mg19. Manganese 5mg20. Phosphorus 1400mg20. Selenium 300mcg21. Z<strong>in</strong>c 25mg(Note: * For pre and antenatal use, as part of a multivitam<strong>in</strong> and m<strong>in</strong>eralpreparation, levels higher than the 20mg limit established for adults may bepermitted at the discretion of the DCA)


Supportive documents:-GRAS status (USFDA)-Status at other reference countries likehealth canada, therapeutics goodsadm<strong>in</strong>istration (TGA)-Standard reference on the <strong>in</strong>dication and-Safety use as a health supplement product-Journals


Non permitted/ banned <strong>in</strong>gredients•Vitam<strong>in</strong> K•Conjugated L<strong>in</strong>oleic acid (CLA)•Glucosam<strong>in</strong>e•Boric acid/ borax•Banned probiotics:oBACILLUS COAGULANS (LACTOBACILLUS SPOROGENES)oENTEROCOCCUS FAECIUMoENTEROCOCCUS FAECALIS(Potential pathogenic bacterium, <strong>in</strong>adequate evidence of safety tojustify their use as probiotic)(Appendix 6 Drug Registration Guidance Document)


Non permitted/ banned <strong>in</strong>gredients


Warn<strong>in</strong>g labels (refer appendix 2DRGD)Bee Pollen/PropolisG<strong>in</strong>sengAlfalfaAspartameArg<strong>in</strong><strong>in</strong>e


Compulsory:Warn<strong>in</strong>g labels (refer appendix 2 DRGD)L-ARGININEArg<strong>in</strong><strong>in</strong>e is not recommended for patients follow<strong>in</strong>g a heart attack‘CHITOSAN, CHONDROITIN, FISH OILDerived from seafoodGINSENGsafe use of g<strong>in</strong>seng <strong>in</strong> pregnant women and children has not been establisheddo not exceed the stated dosesafety on long term use has not been establishedASPARTAMEUnsuitable for phenylketonurics


PRODUCT INFORMATION:Warn<strong>in</strong>gs/precautions/drug <strong>in</strong>teractions/adverseeffectsALFALFA (MEDICAGO SATIVA)This product conta<strong>in</strong>s Alfalfa (Medicago sativa).Individuals with a predisposition to systemic lupus erythematosus should consult theirphysician before consum<strong>in</strong>g this productBEE POLLENThis product conta<strong>in</strong>s Bee Pollen and may cause severe allergic reactions, <strong>in</strong>clud<strong>in</strong>gfatal anaphylactic reactions <strong>in</strong> susceptible <strong>in</strong>dividuals.Asthma and allergy sufferers may be at greater risksROYAL JELLYThis product conta<strong>in</strong>s royal jelly and may cause severe allergic reactions <strong>in</strong>clud<strong>in</strong>gfatal anaphylactic reactions <strong>in</strong> susceptible <strong>in</strong>dividualsAsthma and allergy sufferers may be at the greater risks(Appendix 3 Drug Registration Guidance Document)


INGREDIENTS DERIVEDFROM SEAFOODAdditional data required:-Diox<strong>in</strong> level certificate/ results analysis(f<strong>in</strong>ished product/ raw active <strong>in</strong>gredient)-The certificate must have specification and results


PRODUCT CONTAINING PLACENTAAdditional data required:Hormone test certificate:-Must have specification of detection limit and results, ma<strong>in</strong>ly on estrogen,progestrogen and testosteroneLetter of declaration :-Additional letter from the manufacturer stat<strong>in</strong>g that the placenta <strong>in</strong> theformulation is hormone free, which means are no added hormone


LABELING REQUIREMENTS


Non Permissible Name


QUALITYHEALTH SUPPLEMENTSREGISTRATION CRITERIAImported product:- Certificate of Pharmaceutical Product or- Certificate of Free Sale- GMP Certificate: Have to comply with current GoodManufactur<strong>in</strong>g Practices (GMP) requirements(<strong>in</strong>frastructure /facilities, personnel, processes andcontrols)Local product:- Manufacturer’s Licence


HEALTH SUPPLEMENTSREGISTRATION CRITERIAQUALITYShould conform to set standards of quality:-Product Specifications: Assay-Raw materials (CoA)-F<strong>in</strong>ished Product Quality Control (FPQC)-Stability Data-Heavy metals : Pb, Hg, As, Cd-Microbial Limit Test: bacteria, fungi, specifiedmicroorganism-Dis<strong>in</strong>tegration test, Weight of Uniformity Test-Manufactur<strong>in</strong>g process-In-process Quality Control (IPQC)


Specifications:Heavy Metal TestMercury - not more than 0.5 ppmArsenic - not more than 5.0 ppmLead - not more than 10 ppmCadmium -not more than 0.3 ppm


Lab Result- example-


HEALTH SUPPLEMENTSREGISTRATION CRITERIAQUALITYIndication:- Allowed to be <strong>in</strong>dicated as “Dietary / Food/ Health Supplement”.Claims:-Supplements may not bear disease claims (ie capable of cur<strong>in</strong>g, treat<strong>in</strong>gor prevent<strong>in</strong>g disease); either explicit or implied.-Functional claims which describe the physiological role of the nutrient <strong>in</strong>normal function<strong>in</strong>g of the body may be permitted-Claim for active <strong>in</strong>gredients and not for productRefer to Appendix 9 DRGD


Functional Claims


Pack SizeMaximum pack size allowed for tablets, pills, capsules is based ondaily dos<strong>in</strong>g for a quantity not exceed<strong>in</strong>g six (6) months usage.Shape of tabletAnimal shapes tablet are not allowed.Susta<strong>in</strong>ed release and Timed release dosage formProtocol of analysis, In- Process Quality Control (IPQC), F<strong>in</strong>ishedProduct Specification (FPQC) and Certificate of Analysis (COA)should be submitted.


‘Food –DrugInterface’47


Classification Guidel<strong>in</strong>eFood?Drug?Product“Food-Drug Interface”


Product “Food-DrugInterface”Classifications of Product is through “Food-Drug Interface”by : Food-Drug Interface classification committee- National Pharmaceutical Control Bureau, NPCB- Food Safety and Quality Division, FSQDM<strong>in</strong>istry Health of <strong>Malaysia</strong>Appendix 10 ; Guide to classification of Food-Drug Interface Products“ Drug Registration Guidance Document ”


Guide to Classification of Food-Drug Interface Products(Guide to determ<strong>in</strong><strong>in</strong>g if a product is to be regulated by the NPCB/FSQD)


Produk “Food-DrugInterface”BKKM• >80% - food base<strong>in</strong>gredientBPFK•


Key Po<strong>in</strong>ts For ClassificationWhen polysaccharides (e.g ;maltodextr<strong>in</strong>) are present <strong>in</strong> capsule form,they shall be considered as excipient and shall not be <strong>in</strong>cluded <strong>in</strong>determ<strong>in</strong><strong>in</strong>g the percentage of active <strong>in</strong>gredientPermitted probiotics when present by itself s<strong>in</strong>gly or <strong>in</strong> comb<strong>in</strong>ation <strong>in</strong>capsule or tablet form shall be regulated under BPFK and shall conta<strong>in</strong>m<strong>in</strong>imum 10 6 viable cells/g of the viable cells for each stra<strong>in</strong>.Permitted probiotics when present <strong>in</strong> foods shall be treated as food<strong>in</strong>gredients and shall conta<strong>in</strong> m<strong>in</strong>imum 10 6 viable cells/g of the viablecells for each stra<strong>in</strong>.Product Classification Form : BPFK-003


Key Po<strong>in</strong>ts For ClassificationAll prote<strong>in</strong> based <strong>in</strong>gredients (e.g – case<strong>in</strong>, whey, soy prote<strong>in</strong>) shall betreated as food <strong>in</strong>gredients even though they are present <strong>in</strong>pharmaceutical dosage form.Any foods or comb<strong>in</strong>ation of foods may be regulated under BKKM eventhough they are present <strong>in</strong> capsule, softgel, tablet or sachet is to bedecided together with the <strong>in</strong>tended use.Capsules conta<strong>in</strong><strong>in</strong>g one or more natural <strong>in</strong>gredients that are nottraditionally used as food shall be regulated under BPFKOils that are not traditionally used as food or comb<strong>in</strong>ation e.g even<strong>in</strong>gprimrose oil, garlic oil, fish oil, flaxseed oil and grapeseed oil <strong>in</strong> capsuleor softgel shall be regulated under BPFK.


Key Po<strong>in</strong>ts For Classification Substances listed <strong>in</strong> the prohibited <strong>in</strong>gredient list of the Drug RegistrationGuidance Document (DRGD) shall not be permitted for used <strong>in</strong> anyproducts. Dietary fibre <strong>in</strong>cludes <strong>in</strong>ul<strong>in</strong>, fructooligosacharrides,galactooligosacharrides, polydextrose, acacia gum, oat soluble fibre,resistant dextrose and resistant maltodextr<strong>in</strong>e The follow<strong>in</strong>g <strong>in</strong>gredients do not follow 20: 80 Decision Tree:-Plant stanol/ sterol & esters (>3.5g/day under BPFK)-Psyllium Husk (>3.5g/day under BPFK)-Schedule Poisons (BPFK)-Probiotics more than 10 6 viable cell/gBorang pengkelasan produk: BPFK-003


MiscellanousTea SachetHerbal tea product <strong>in</strong> sachet form is regulated under circular of DrugControl Authority (bil 11) <strong>in</strong> bpfk/02/5/1.3 <strong>in</strong> which herbal tea <strong>in</strong> sachetthat has medical claim only will be controlled and need to be registeredwith Drug Control Authority (DCA).LozengesThe <strong>in</strong>dustrial company is not allowed to put the word ’lozenges’ on foodproduct.Borang pengkelasan produk: BPFK-003


Reasons for product to be rejectedIncomplete DocumentConta<strong>in</strong>s banned <strong>in</strong>gredientsDoes not comply to GMPInappropriate GMP authority


REFERENCESReferences


REFERENCES


Registered Product59


Registered ProductRegistration Number: eg. MAL100604653X (with C, R, S, (E)Product holder is allowed to do certa<strong>in</strong> changes on the registeredproduct through ‘variation’ through onl<strong>in</strong>e.Registered product will be check through surveilansRegistered product validity: 5 yearsRe<strong>registration</strong> need to be done every 5 years, to ensure the registeredstatus. Six months before the validity of <strong>registration</strong> expires need to besubmitted.


SUMMARY61


Policy-change of policy time to timeNew technology/ era-Have to be updated, eg: bilayer technologyNew <strong>in</strong>vention by applicant-New dosage form, extended release/slowrelease, <strong>in</strong>creased standards-Client charter on time to register ,eg: s<strong>in</strong>gle<strong>in</strong>gredient 60 work<strong>in</strong>g days, comb<strong>in</strong>ation<strong>in</strong>gredient 90 work<strong>in</strong>g days


- Pharmaceutical Services Division :www.pharmacy.gov.my- National Pharmaceutical Control Bureau :www.bpfk.gov.my63

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!